Epstein Secrets

ion at the poor state of relations between the intelligence community and the Trump Administration." Russ Travers, who served as acting director of the National Counterterrorism Center, told NPR's Mary Louise Kelly, co-host of 'All Things Considered,' in his first broadcast interview since leaving his government post, "If people b

re Will Not Compromise Vaccine Safety. USA Today (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Moderna and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety

ion at the poor state of relations between the intelligence community and the Trump Administration." Russ Travers, who served as acting director of the National Counterterrorism Center, told NPR's Mary Louise Kelly, co-host of 'All Things Considered,' in his first broadcast interview since leaving his government post, "If people b

re Will Not Compromise Vaccine Safety. USA Today (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Moderna and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety

ion at the poor state of relations between the intelligence community and the Trump Administration." Russ Travers, who served as acting director of the National Counterterrorism Center, told NPR's Mary Louise Kelly, co-host of `All Things Considered,' in his first broadcast interview since leaving his government post, "If people b

re Will Not Compromise Vaccine Safety. USA Today (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Moderna and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety